DMAA - NASDAQ

Drugs Made In America Acquisition Corp. Ordinary Shares

DMAA·NASDAQ

$10.61

+0.094%

Financial ServicesShell Companies

Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$357.74M

EPS0.1900

P/E Ratio55.84

Earnings Date—

dmaa

Other Total Stockholders' Equity

Last Annual Value

0.00

3-Year CAGR

5-Year CAGR

10-Year CAGR

Adjust for Inflation

Drugs Made In America Acquisition Corp. Ordinary Shares Competitors Analysis of Other Total Stockholders' Equity

DMAA · NASDAQ

Company	CAGR 3Y	CAGR 5Y	CAGR 10Y
Drugs Made In America Acquisition Corp. Ordinary Shares NASDAQ:DMAA	N/A	N/A	N/A
SIM Acquisition Corp. I NASDAQ:SIMA	N/A	N/A	N/A
Centurion Acquisition Corp. NASDAQ:ALF	N/A	N/A	N/A
Titan Acquisition Corp. NASDAQ:TACH	N/A	N/A	N/A
Oyster Enterprises II Acquisition Corp NASDAQ:OYSE	N/A	N/A	N/A
Live Oak Acquisition Corp. V Class A Ordinary Shares NASDAQ:LOKV	N/A	N/A	N/A
Renatus Tactical Acquisition Corp I Class A Ordinary Shares NASDAQ:RTAC	N/A	N/A	N/A
Berto Acquisition Corp. Unit NASDAQ:TACOU	N/A	N/A	N/A
Berto Acquisition Corp. NASDAQ:TACO	N/A	N/A	N/A

Drugs Made In America Acquisition Corp. Ordinary Shares Fair Value Envelope

DMAA · NASDAQ

Our analysis suggests that DMAA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $10.61, this represents a potential HIDDEN relative to our calculated worth for Drugs Made In America Acquisition Corp. Ordinary Shares.

HIDDEN

Intrinsic Value

Current Price: $10.61

Related Guides

Blog Categories

Continue your DMAA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.